Early evaluation critical for kidney disease patients’ survival
“We need to get (chronic kidney disease) on the radar screen, especially when theres a medical history of high blood pressure or diabetes, so both patients and physicians are more aware of the consequences and opportunities to intervene.” – Neil R. Powe, M.D., M.P.H.
Kidney disease patients are at a much increased risk of death when they have delays getting to a specialist, a Johns Hopkins-led study shows. Delays occur more often among black males, the uninsured and those who have multiple illnesses.
Results of the study, published in the Sept. 17 issue of the Annals of Internal Medicine, show that a third of chronic kidney disease patients were evaluated by a nephrologist only four months before having to start life-saving dialysis treatment. Those evaluated late were more likely to die within two years after starting dialysis. Delayed evaluation typically is associated with a higher risk of unplanned first dialysis and complications as well as increased hospital costs and length of stay.
While the study did not examine reasons for the delay in getting specialty care, senior author Neil R. Powe, M.D., M.P.H., M.B.A., says these probably include poor access to primary care, delayed or absent referral to a specialist from a primary care doctor and patients lack of information about the importance of early intervention.
“There also are many people who have chronic kidney disease and may not know it, so they may not be under a physicians care,” says Powe, director of Hopkins Welch Center for Prevention, Epidemiology and Clinical Research. “We need to get the condition on the radar screen, especially when theres a medical history of high blood pressure or diabetes, so both patients and physicians are more aware of the consequences and opportunities to intervene. These patients should be under the care of a doctor and should talk to their doctors about seeing a nephrologist before their disease progresses to the point at which they need dialysis.”
Powe and colleagues examined data from the Choices for Healthy Outcomes in Caring for End-stage renal disease (CHOICE) Study, a Hopkins effort that followed more than 1,000 dialysis patients nationwide between October 1995 and June 1998. For this study, they reviewed information on 828 patients just starting dialysis, asking them to complete a questionnaire on their medical and social history and provide the month and year in which they first visited a nephrologist.
They also compared the time between each patients first visit to a nephrologist and the start of his or her dialysis program. They defined early evaluation as first seeing a nephrologist more than a year before the start of dialysis and late evaluation as first seeing a nephrologist less than four months before dialysis. Patient survival rates were tracked for two years.
Thirty percent of patients were seen by a nephrologist less than four months prior to starting dialysis, compared to 22 percent evaluated between four and 12 months before dialysis, and 48 percent evaluated more than a year before dialysis. Late evaluation was more common among black men than white men (45 percent versus 25 percent), uninsured patients than insured patients (57 percent versus 29 percent) and patients with severe co-existing disease than those with mild or no co-existing disease (35 percent versus 23 percent). Those evaluated late were less likely to have received erythropoeitin, a hormone necessary to boost red blood cell production.
During an average follow-up period of 2.2 years, 201 of the patients died. Among those who were evaluated late, death rates were 13 percent one year after starting dialysis and 28 percent two years after starting dialysis. By comparison, among those evaluated early, the death rates were 4 percent and 15 percent, respectively.
Approximately 8 million people in the United States have moderate kidney disease, and another 300,000 have end-stage renal disease (ESRD), Powe says. Annual U.S. spending related to treatment of ESRD exceeds $15 billion. The patient population studied was 55 percent male, 28 percent black and 65 percent younger than age 65.
Alle Nachrichten aus der Kategorie: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
New machine learning tool tracks urban traffic congestion
UBER driver data helps track and potentially alleviate urban traffic congestion. A new machine learning algorithm is poised to help urban transportation analysts relieve bottlenecks and chokepoints that routinely snarl…
Voyager spacecraft detect new type of solar electron burst
Physicists report accelerated electrons linked with cosmic rays. More than 40 years since they launched, the Voyager spacecraft are still making discoveries. In a new study, a team of physicists…
Cooling electronics efficiently with graphene-enhanced heat pipes
Researchers at Chalmers University of Technology, Sweden, have found that graphene-based heat pipes can help solve the problems of cooling electronics and power systems used in avionics, data centres, and…